EUVIMEDEUVIMED entdecken
Open Access

The association between human papillomavirus type 16 seropositivity and oropharyngeal cancer among men living with HIV

Ashley J Duff iD, Anna Junkins, Li Chen, Kyle Mannion, Michael C Topf, Tim Waterboer, Birgitta E Michels, Julia Butt, Beverly O Woodward, Morgan C Lima, Husamettin Erdem, Michael A Leonard und 3 weitere

Cancer · 2025

DOI: 10.1002/cncr.70167 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer, 2025. Verfasst von Ashley J Duff und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Environmental Health, College of Public Health, University of Kentucky, Lexington, Kentucky, USA. Hauptthemen laut MEDLINE: Oropharyngeal Neoplasms, Human papillomavirus 16, Papillomavirus Infections, HIV Infections. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDCR NIH HHS, NCI NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There are no methods for the early detection of human papillomavirus–driven oropharyngeal squamous cell carcinoma (HPV+OPSCC); however, HPV16 E6 seropositivity has been identified as a promising screening marker. Although people living with HIV have a higher risk of developing HPV+OPSCC, few studies have evaluated the association between HPV16 antibodies and HPV+OPSCC.

Methods

The association between HPV16 seropositivity (L1, E1, E2, E4, E6, and E7) and OPSCC was assessed among 2331 men living with HIV (MLWH) aged ≥40 years who had blood specimens banked within the Tennessee Center for AIDS Research biorepository between 2001 and 2019; some samples were collected before OPSCC diagnosis, and others after. The association between HPV16 seropositivity and OPSCC was analyzed via univariable logistic regression.

Results

One hundred and thirty‐five HPV16 E6 seropositive cases and 11 OPSCC cases were identified. HPV16 E6 seropositivity was associated with a 14‐fold higher odds of OPSCC (odds ratio [OR], 14.04; 95% CI, 4.23–46.61; p < .001); five of the 11 OPSCC cases were HPV16 E6 seropositive (sensitivity, 45%; 95% CI, 17%–77%) compared to 6% of controls (specificity, 94%; 95% CI, 93%–95%). Seroreactivity against HPV16 E1 (OR, 7.14; 95% CI, 1.52–33.67; p = .013), HPV16 E2 (OR, 16.43; 95% CI, 4.94–54.65; p < .001), and HPV16 E7 (OR, 13.84; 95% CI, 3.99–48.11; p < .001) was also significantly associated with OPSCC. HPV16 E6 antibodies were detectable up to 9 years before and 19 years after OPSCC diagnosis.

Conclusions

Among MLWH, HPV16 E6 antibodies are strongly associated with OPSCC, yet point estimates of the sensitivity and specificity of HPV16 E6 antibodies for OPSCC were lower compared to studies in populations without HIV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oropharyngeal NeoplasmsHuman papillomavirus 16Papillomavirus InfectionsHIV InfectionsHumansMaleMiddle AgedAdultOncogene Proteins, ViralAntibodies, ViralAgedRepressor Proteins

Stichwörter der Autor:innen

HPVHPV16 E6 antibodieshuman papillomavirusoropharyngeal cancerserology

Substanzen

Oncogene Proteins, ViralAntibodies, ViralE6 protein, Human papillomavirus type 16Repressor Proteins

Autor:innen und Institutionen

  • Department of Epidemiology and Environmental Health, College of Public Health, University of Kentucky, Lexington, Kentucky, USA.
  • Division of Epidemiology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Markey Cancer Center, University of Kentucky, Lexington, Kentucky, USA.
  • Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Division of Infections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

ORCID-Profile: Ashley J Duff, Krystle A Lang Kuhs

Förderung

  • NIDCR NIH HHS
  • NCI NIH HHS
  • NIH HHS
  • NIAID NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Duff, A. J., Junkins, A., Chen, L., Mannion, K., Topf, M. C., Waterboer, T., Michels, B. E., Butt, J., Woodward, B. O., Lima, M. C., Erdem, H., Leonard, M. A., Turner, M. M., Sudenga, S. L., & Lang Kuhs, K. A. (2025). The association between human papillomavirus type 16 seropositivity and oropharyngeal cancer among men living with HIV. Cancer. https://doi.org/10.1002/cncr.70167

Vancouver

Duff AJ, Junkins A, Chen L, Mannion K, Topf MC, Waterboer T, et al. The association between human papillomavirus type 16 seropositivity and oropharyngeal cancer among men living with HIV. Cancer. 2025. doi:10.1002/cncr.70167

BibTeX
@article{Duff2025,
  author = {Duff, Ashley J and Junkins, Anna and Chen, Li and Mannion, Kyle and Topf, Michael C and Waterboer, Tim and Michels, Birgitta E and Butt, Julia and Woodward, Beverly O and Lima, Morgan C and Erdem, Husamettin and Leonard, Michael A and Turner, Megan M and Sudenga, Staci L and Lang Kuhs, Krystle A},
  title = {The association between human papillomavirus type 16 seropositivity and oropharyngeal cancer among men living with HIV},
  journal = {Cancer},
  year = {2025},
  doi = {10.1002/cncr.70167}
}
Kostenlos starten →